How Indiana volleyball walk-on Isa Lopez found storybook ending in Bloomington
Indiana volleyball senior Isa Lopez gets storybook ending in Bloomington after series of setbacks nearly ended her career
Source: aol.com
📰 Ping Cao News
Ping Cao News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ping Cao. Real-time updates on events, politics, business and more.
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with PT Kalbe Genexine Biologics ("KGbio"), an...
Source: prnewswire.com
BridGene Biosciences Achieves the Second Preclinical Milestone in Takeda Collaboration
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company that uses proprietary chemoproteomics technology to discover and develop small molecules...
Dave Schemelia Daniel Kontoh Boateng Bridgene Biosciences Eric Reiss Bridgene Biosciences Inc Vigene Biosciences
Source: prnewswire.com
BridGene Biosciences to Present Data from Two Preclinical Studies at 34th EORTC-NCI-AACR Symposium 2022
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for...
Source: prnewswire.com
BridGene raises $38.5m to develop IMTAC platform and cancer drugs
BridGene has raised $38.5m in Series B financing round to develop its chemoproteomic platform, IMTAC, as well as oncology drugs.
BridGene Biosciences Raises $38.5M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company leveraging a proprietary chemoproteomic platform to discover and develop small-molecule...
Source: prnewswire.com
BridGene Biosciences Announces Acceptance of Two Abstracts for Poster Presentations at Cambridge Health Institute's Inaugural Drug Discovery Chemistry Conference
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high...
Source: prnewswire.com
BridGene Biosciences Announces Research Collaboration with the Peter MacCallum Cancer Centre to Discover Targets and Small Molecule Drug Candidates for Ovarian Cancer
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high...
Source: prnewswire.com
BridGene Biosciences Announces Research Collaboration with the Peter MacCallum Cancer Centre to Discover Targets and Small Molecule Drug Candidates for Ovarian Cancer
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high...
Source: prnewswire.com